Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition
The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.
The Pharma Letter2h
PhRMA calls on Congress to ensure savings go to patients, not PBMs
The US trade group Pharmaceutical Research and Manufacturers of America (PhRMA) today launched new advertisements urging ...
Cedar Rapids KCRG-TV on MSN3d
Pharmacy Owner says pharmacy closures pose major risk to patient access
I visited a pharmacy earlier this year that is dispensing twice as many prescriptions as when they opened five years ago, but ...
Fact check: Baldwin falls short with claim on Hovde’s stance on prescription drug prices
Sen. Baldwin says opponent Hovde “opposes efforts to negotiate with the big pharmaceutical companies to lower the price of ...
Opinion: Pharmacy benefit management – The prescription benefit “shell game”?
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Insurancenewsnet.com4d
Pharmacy Benefit Manager math: Big chains paid $23.55 to fill a blood pressure Rx. Small drugstores paid $1.51
Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...
Times Union4d
Commentary: Pharmacy benefit managers are a roadblock to affordable medications
A New York Times report found that pharmacy benefit managers push patients toward medications with higher out-of-pocket costs to increase their own profits. Additionally, PBMs often negotiate ...
JD Supra12d
Evolving pharmacy landscape signals more stringent regulatory scrutiny of “patient steering”
The pharmacy landscape has evolved considerably over the past year, shining a spotlight on pharmacy “patient steering”, the ...
JD Supra12d
Stakeholders Raise 340B Concerns in Medicaid Drug Rebate Program Final Rule; CMS, With Hands Tied, Shrugs
On September 26, 2024, the Centers for Medicare & Medicaid Services (CMS) released a final rule implementing changes to the ...
Blue Shield Of California Push For Cheaper Biosimilars Could Disrupt Market
Blue Shield of Calif. is bypassing traditional pharmacy benefit managers to bring a Humira-referenced biosimilar, Idacio, to ...
Verona Pharma Faces Financial Risks Amid Medicaid Rebate Program Compliance Challenges
Verona Pharma (VRNA) has disclosed a new risk, in the Litigation & Legal Liabilities category. Verona Pharma faces significant business ...
LA Times on MSN3d
Arizona voters back homeless crackdown. Will other states follow?
Even if taxpayers do not end up collecting rebates, people on both sides of the issue believe ... that taxpayers aren’t going ...